fungating carcinoma - significado y definición. Qué es fungating carcinoma
Diclib.com
Diccionario ChatGPT
Ingrese una palabra o frase en cualquier idioma 👆
Idioma:

Traducción y análisis de palabras por inteligencia artificial ChatGPT

En esta página puede obtener un análisis detallado de una palabra o frase, producido utilizando la mejor tecnología de inteligencia artificial hasta la fecha:

  • cómo se usa la palabra
  • frecuencia de uso
  • se utiliza con más frecuencia en el habla oral o escrita
  • opciones de traducción
  • ejemplos de uso (varias frases con traducción)
  • etimología

Qué (quién) es fungating carcinoma - definición

HUMAN DISEASE
Invasive ductal carcinoma; Ductal mammary carcinoma; Infiltrating ductal carcinoma; Mammary ductal carcinoma; Breast invasive carcinoma
  • [[Mastectomy]] specimen containing a very large invasive ductal carcinoma of the breast. To the right, the [[nipple]] can be seen on the pink skin, while in the center of the picture a large blue and pink swelling or tumor can be seen. Blood stained fat tissue is seen at the cut margins.
  • Non-specific skin changes that may be signs of breast cancer.

Embryonal carcinoma         
EMBRYONAL CANCER THAT IS A TYPE OF GERM CELL TUMOUR, LOCATED IN THE OVARIES OR TESTES
Carcinoma, embryonal
Embryonal carcinoma is a relatively uncommon type of germ cell tumour that occurs in the ovaries and testes.
carcinoma         
CELL TYPE CANCER THAT HAS MATERIAL BASIS IN ABNORMALLY PROLIFERATING CELLS DERIVES FROM EPITHELIAL CELLS
Heptocellular carcinoma; Carcinomas; Carcinomatous; Carcinom; Intraepidermal carcinoma; Carcinoma of penis
(carcinomas)
1.
Carcinoma is a type of cancer. (MEDICAL)
N-UNCOUNT
2.
Carcinomas are malignant tumours. (MEDICAL)
N-COUNT
Carcinoma         
CELL TYPE CANCER THAT HAS MATERIAL BASIS IN ABNORMALLY PROLIFERATING CELLS DERIVES FROM EPITHELIAL CELLS
Heptocellular carcinoma; Carcinomas; Carcinomatous; Carcinom; Intraepidermal carcinoma; Carcinoma of penis
Carcinoma is a malignancy that develops from epithelial cells. Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.

Wikipedia

Invasive carcinoma of no special type

Invasive carcinoma of no special type (NST) is also referred to as invasive ductal carcinoma or infiltrating ductal carcinoma (IDC) and invasive ductal carcinoma, not otherwise specified (NOS). Each of these terms represents to the same disease entity, but for international audiences this article will use invasive carcinoma NST because it is the preferred term of the World Health Organization (WHO).

Invasive carcinoma NST accounts for half of all breast cancer diagnoses in women and is the most common type of invasive breast cancer. It is also the most commonly diagnosed form of male breast cancer. Invasive carcinoma NST is classified by its microscopic, molecular, and genetic features. Microscopically it is a breast carcinoma originating from the breast ducts that shows invasive features but lacks the "specific differentiating features" of other types of invasive breast cancers. Invasive carcinoma NST is a diagnosis of exclusion, which means that for the diagnosis to be made all the other specific types must be ruled out. There are several rare sub-types of invasive carcinoma NST including pleomorphic carcinoma, carcinoma with osteoclast-like stromal giant cells, carcinoma with choriocarcinomatous features, and carcinoma with melanotic features.

Invasive breast carcinomas are most common in White women, followed by Black and Hispanic women. Black women tend to have greater severity of disease at diagnosis with worse overall survival. Breast cancer is often asymptomatic and diagnosis by screening, but may present with symptoms of pain, palpable mass, skin changes, or complications of metastasis.

Clinical disease or suspicious lesions on screening may evaluated further with tissue sampling. Diagnostic analysis will include histopathological typing, grading, and analysis for DNA markers and receptor-status. The prognosis for patients with invasive carcinoma NST is heterogenous and difficult to predict for every individual. However, general factors such as high tumor grade, stage, receptor negativity, BRCA1-positivity suggest higher risk of recurrence and lower overall survival. Treatment is individualized however most patients are offered some combination of neoadjuvant, surgical, radiation, and adjuvant systemic medical therapies.